Track the 메타케어 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 메타케어 has published 63 reports. Market capitalisation: €21.5bn. The latest transaction was filed on 29 June 2026 (Purchase). Among the most active insiders: 초록뱀미디어. The full history is accessible without an account.
63
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
9 ops.
Sell Volume
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,081 of 29,063 companies
28.6
score / 100
Value
30
Quality
27
FCF yld-21%
Earn yld2.2%
EV/EBITDA14.9x
ROE-1.4%
Gross mgn30%
Net mgn1.5%
Debt/EBITDA10.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
MetaCare es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se enfoca en desarrollar soluciones innovadoras para mejorar la atención médica.